InnovAge (INNV) stock in plain English
Every company we rate gets Strong Buy, Buy, Buy with Caution, Hold or Sell. Members see the rating for this company and the five scores behind it.
Change shown by the quote provider. Data may be delayed.
What does InnovAge (INNV) do?
InnovAge Holding Corp (INNV) is a U.S.-listed company in Healthcare (Medical Care Facilities). What it does: Provides all-inclusive medical care, adult day programs, and in-home assistance to frail elderly participants. Operates comprehensive care centers managing all medical and daily social services for frail seniors living at home. It is worth $1.22B on the market and sold $1.02B over the last year.
- Market cap
- $1.22B
- P/E ratio
- 139.7×
- Annual sales
- $1.02B
- Sector
- Healthcare
- Industry
- Medical Care Facilities
- Brief updated
- Nov 16, 2026
INNV’s flags, in plain English
Each flag is a number from InnovAge’s reports to the SEC or from market data, with the reason it matters. This brief was updated on Nov 16, 2026.
Earnings Jumping
Profits up 2435% this year. Profit per share is growing fast this year. One year does not make a trend, so check whether sales grew too.
Insiders Hold
Insiders own 76.6% of the company. The people who run the company own a meaningful slice of it, so they gain or lose along with other shareholders.
Low debt
Low debt, only 33% of shareholder equity. The company owes very little compared with what it earns, so a bad year is less likely to force its hand.
Priced for Perfection
Priced at 139.7 times its yearly profit, so a lot of growth is already expected. The share price already assumes strong results, so news that is merely good can still send it down.
2 more green flags and 2 more risk notes open with the free trial. Try it free for 7 days.
Questions about INNV
How big is InnovAge?
InnovAge’s market cap is $1.22B: what all of its shares are worth together at today’s price. Its annual sales (revenue) are $1.02B: what customers paid the company over the last year, before any costs.
What is INNV’s P/E ratio?
INNV’s P/E ratio is 139.7×. Investors pay about 139.7 dollars for each dollar of the company’s yearly profit. A low number can mean a bargain or a problem, so read it next to the flags.
What could go wrong with INNV?
The business depends entirely on fixed reimbursement rates set by Medicare and state Medicaid programs. That is one risk on InnovAge’s card. Its first risk flag is Priced for Perfection, explained above. The card holds 2 more risk notes for trial accounts. A flag reads what the company reported. It does not predict the price.
Where do these numbers come from?
From InnovAge’s own reports to the SEC (annual and quarterly) and from market data. Every company runs through the same scoring formula, and a reviewer spot-checks cards against the source data. INNV’s filings on SEC.gov. The Margin Monkey is research, not advice.
